Established Cytogenetics Expert DCI is an established independent cytogenetics lab with CAP accreditation and CLIA certification, offering clinical and stem cell karyotyping and FISH with rapid turnaround. This positions it well as a trusted outsource partner for clinics, hospitals, academic medical centers, and biotech companies seeking reliable cytogenetics testing and fast SLAs.

FISH QC Outsourcing Their FISH quality control services, backed by decades of experience, enable clients to build or improve internal FISH capabilities without hiring in house experts. This creates sales opportunities with labs expanding cytogenetics programs, CROs needing QC support, and biotech firms integrating cytogenetics into product development.

Cross Sector Clients DCI serves clinical, research, and biotech clients, including stem cell lines, indicating cross-sell opportunities to labs and CROs that require both diagnostic and research grade cytogenetics. Potential to partner on testing for stem cell banks or gene therapy studies.

Rapid Turnaround The firm emphasizes rapid turnaround times, a critical differentiator for hospital labs and stem cell work. Offering service level agreements, volume pricing, and predictable delivery could win contracts from high demand clients.

Partnership Growth DCI’s small size suggests partnership potential for growth through white label arrangements, referral agreements, or regional collaborations with larger labs or hospital networks on the West Coast. This could scale testing volumes while leveraging DCI’s niche expertise.